Tandem key facts
as of Oct 2026- Developer of an AI-based healthcare data platform designed for clinics to revolutionize healthcare workflows and delivery.
- Tandem is valued at approximately $652.9M as of Oct 2026, set at its Series B, Sep 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $59.2M across 1 recorded rounds; the latest was Series B ($100.0M) in Sep 2026.
- Notable investors include Northzone Ventures, Visionaries Club, Greens Ventures, Amino Collective, Kinnevik.
- Status: Privately Held (backing).
Valued at $652.9M at its Series B, Sep 2026. Nothing has traded since.
- ·The post-money valuation on its round
- ·Watch Tandem: the Monday email on marks, rounds and moves
Tandem funding rounds
1 roundsTandem valuation
Tandem was valued at $653 million at its Series B in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
Recent activity
In the last 90 days, Tandem's record added 1 funding round.
How much has Tandem raised?
Tandem has raised $59.2 million across 1 recorded round since 2026. The largest was a $100 million Series B in Sep 2026. 1 of the rounds disclosed a post-money valuation.
Tandem investors
5 investors are on record for Tandem, including Northzone Ventures, Visionaries Club, Greens Ventures and Amino Collective. The Series B in Sep 2026 drew 5 investors.
About Tandem
Developer of an AI-based healthcare data platform designed for clinics to revolutionize healthcare workflows and delivery. The company's platform supports clinicians with medical note taking, coding, and other administrative tasks, enabling clinicians to focus on providing care rather than spending their time on administrative tasks.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2023
- Employees
- 130
- Website
- tandemhealth.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.